Scheffler, M., Kobe, C., Zander, T., Nogova, L., Kahraman, D., Thomas, R. K., et al. (2012). Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [ 18F]fluorothymidine (FLT-)PET. Lung Cancer, 77(3), 617-620. doi:10.1016/j.lungcan.2012.05.110.